Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Bio-Techne Corporation (TECH)

191.63   3.08 (1.63%) 02-15 16:00
Open: 189.4 Pre. Close: 188.55
High: 191.77 Low: 189.05
Volume: 153,874 Market Cap: 7237M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 191.987 - 192.749 192.749 - 193.406
Low: 186.927 - 187.875 187.875 - 188.691
Close: 189.995 - 191.54 191.54 - 192.87

Technical analysis

as of: 2019-02-15 4:43:27 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 225.97     One year: 263.94
Support: Support1: 166.26    Support2: 149.44
Resistance: Resistance1: 193.47    Resistance2: 225.97
Pivot: 180.55
Moving Average: MA(5): 187.94     MA(20): 176.05
MA(100): 168.72     MA(250): 163.41
MACD: MACD(12,26): 8.80     Signal(9): 7.87
Stochastic oscillator: %K(14,3): 88.48     %D(3): 83.91
RSI: RSI(14): 77.67
52-week: High: 206.04  Low: 132.75  Change(%): 35.7
Average Vol(K): 3-Month: 23628  10-Days: 25659

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
TECH has closed below upper band by 18.9%. Bollinger Bands are 49.4% wider than normal. The large width of the bands suggest high volatility as compared to TECH's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

2019-02-05T15:41:05-05:00
Bio-Techne Corp. (TECH) CEO Chuck Kummeth on Q2 2019 Results - Earnings Call Transcript

2019-02-05T08:00:35-05:00
Bio-Techne Q2 top line up 13%

2019-02-05T06:34:02-05:00
Bio-Techne beats by $0.08, beats on revenue

2019-02-05T06:30:00-05:00
Bio-Techne Declares Dividend

2019-02-05T06:30:00-05:00
Bio-Techne Releases Second Quarter Fiscal 2019 Results

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 37.77
Shares Float (M) 36.37
% Held by Insiders
% Held by Institutions 134.50
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 3.960
EPS Est. Current Year 3.990
EPS Est. Next Year 4.390
EPS Est. Next Quarter 0.920
Forward EPS 4.910
Book Value (p.s.) 6.050
PEG Ratio 3.79
Profit Margin 14.80
Operating Margin 23.72
Return on Assets (ttm) 5.8
Return on Equity (ttm) 10.1
Qtrly Rev. Growth 12.7
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 9.70
Operating Cash Flow (M) 165.12
Levered Free Cash Flow (M) 103.02

Stock Valuations

P/E 48.39
P/E Growth Ratio 0.02
P/BV 31.67
P/S 411008832.00
P/CF 43.83

Dividends & Splits

Dividend 0.697
Dividend Yield
Dividend Pay Date 2018-11-23
Ex-Dividend Date 2019-02-14
Forward Dividend 1.280
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.